Identification of non-covalent SARS-CoV-2 main protease inhibitors by a virtual screen of commercially available drug-like compounds

[Figure: see text]

Detalles Bibliográficos
Autores principales: Zhang, Linlin, Howland, McClane, Hilgenfeld, Rolf, Anderson, Marc O., Eagon, Scott
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759700/
https://www.ncbi.nlm.nih.gov/pubmed/33775840
http://dx.doi.org/10.1016/j.bmcl.2021.127990
_version_ 1784852290587328512
author Zhang, Linlin
Howland, McClane
Hilgenfeld, Rolf
Anderson, Marc O.
Eagon, Scott
author_facet Zhang, Linlin
Howland, McClane
Hilgenfeld, Rolf
Anderson, Marc O.
Eagon, Scott
author_sort Zhang, Linlin
collection PubMed
description [Figure: see text]
format Online
Article
Text
id pubmed-9759700
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Author(s). Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-97597002022-12-19 Identification of non-covalent SARS-CoV-2 main protease inhibitors by a virtual screen of commercially available drug-like compounds Zhang, Linlin Howland, McClane Hilgenfeld, Rolf Anderson, Marc O. Eagon, Scott Bioorg Med Chem Lett Article [Figure: see text] The Author(s). Published by Elsevier Ltd. 2021-06-01 2021-03-26 /pmc/articles/PMC9759700/ /pubmed/33775840 http://dx.doi.org/10.1016/j.bmcl.2021.127990 Text en © 2021 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Zhang, Linlin
Howland, McClane
Hilgenfeld, Rolf
Anderson, Marc O.
Eagon, Scott
Identification of non-covalent SARS-CoV-2 main protease inhibitors by a virtual screen of commercially available drug-like compounds
title Identification of non-covalent SARS-CoV-2 main protease inhibitors by a virtual screen of commercially available drug-like compounds
title_full Identification of non-covalent SARS-CoV-2 main protease inhibitors by a virtual screen of commercially available drug-like compounds
title_fullStr Identification of non-covalent SARS-CoV-2 main protease inhibitors by a virtual screen of commercially available drug-like compounds
title_full_unstemmed Identification of non-covalent SARS-CoV-2 main protease inhibitors by a virtual screen of commercially available drug-like compounds
title_short Identification of non-covalent SARS-CoV-2 main protease inhibitors by a virtual screen of commercially available drug-like compounds
title_sort identification of non-covalent sars-cov-2 main protease inhibitors by a virtual screen of commercially available drug-like compounds
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759700/
https://www.ncbi.nlm.nih.gov/pubmed/33775840
http://dx.doi.org/10.1016/j.bmcl.2021.127990
work_keys_str_mv AT zhanglinlin identificationofnoncovalentsarscov2mainproteaseinhibitorsbyavirtualscreenofcommerciallyavailabledruglikecompounds
AT howlandmcclane identificationofnoncovalentsarscov2mainproteaseinhibitorsbyavirtualscreenofcommerciallyavailabledruglikecompounds
AT hilgenfeldrolf identificationofnoncovalentsarscov2mainproteaseinhibitorsbyavirtualscreenofcommerciallyavailabledruglikecompounds
AT andersonmarco identificationofnoncovalentsarscov2mainproteaseinhibitorsbyavirtualscreenofcommerciallyavailabledruglikecompounds
AT eagonscott identificationofnoncovalentsarscov2mainproteaseinhibitorsbyavirtualscreenofcommerciallyavailabledruglikecompounds

Ejemplares similares